Tabalumab, also as atacicept, represents a unique therapeutic approach for managing autoimmune disorders. This engineered monoclonal immunoglobulin primarily inhibits B cell inducing factor- BAFF, a key molecule https://www.targetmol.com/compound/tabalumab